Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma

被引：0
|
作者：
Kenneth F. Koral
John P. Huberty
Bill Frame
Katherine K. Matthay
John M. Maris
Denise Regan
Daniel Normolle
Gregory A. Yanik
机构：
[1] University of Michigan,Department of Radiology, Nuclear Medicine Division
[2] University of California San Francisco,Department of Nuclear Medicine
[3] University of Michigan Comprehensive Cancer Center,Biostatistics Unit
[4] University of California San Francisco,Department of Pediatrics
[5] Children’s Hospital of Philadelphia,Department of Pediatrics
[6] University of Michigan,Department of Radiation Oncology
[7] University of Michigan,Department of Pediatrics
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词：
Dosimetry; Liver disease; Radionuclide therapy; Iodine-131; MIBG neuroblastoma oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2105 / 2112
页数：7
相关论文
共 50 条
  • [21] Role of [I-131]metaiodobeuzylguanidine (MIBG) in the treatment of neuroblastoma: A review
    Mastrangelo, S
    Servidei, T
    Iavarone, A
    Tornesello, A
    Riccardi, R
    Mastrangelo, R
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1996, 3 (04): : 287 - 295
  • [22] Unusual Delayed Clearance of I-131 MIBG in a Neuroblastoma Patient
    de la Guardia, Miguel
    Corey, Susan
    Barnes, Jaime
    Granger, Meaghan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [23] Physician and Nurse Radiation Exposure During the First Year of Performing I-131 mIBG Therapy
    de la Guardia, Miguel
    Mata, Sophia
    McCammon, Steven
    Barnes, Jaime
    Nielson, Karen
    Granger, Meaghan
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [24] Tumor Dosimetry And Radiobiological Study For High-Activity 131I-mIBG Therapy In The Management Of Refractory/Relapsed Neuroblastoma
    Polito, C.
    Cassano, B.
    Genovese, E.
    Longo, M.
    Donatiello, S.
    Insero, T.
    Valeri, S.
    Villani, M. F.
    Castellano, A.
    Garganese, M. C.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S484 - S484
  • [25] 131I-MIBG therapy with WT-1 peptide for refractory neuroblastoma
    Sugiyama, Minako
    Seigo, Kinuya
    Hosoya, Yosuke
    Iguchi, Akihiro
    Manabe, Atsushi
    PEDIATRICS INTERNATIONAL, 2020, 62 (06) : 746 - 747
  • [26] 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma: An individualised approach
    George, S.
    Kirk, S. J.
    Lancaster, D.
    Vaidya, S. J.
    Mandeville, H.
    Saran, F.
    Chittenden, S.
    Pearson, A. D. J.
    Du, Y.
    Flux, G. D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S352 - S352
  • [27] Necessity of performing I-131 MIBG post-therapy scans in patients with metastatic neuroblastoma
    Yang, Jigang
    Codreanu, Ion
    Servaes, Sabah
    Zhuang, Hongming
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (10) : 1023 - 1024
  • [28] METHODOLOGY AND DOSIMETRY IN ADRENAL-MEDULLARY IMAGING WITH I-131 MIBG
    LINDBERG, S
    FJALLING, M
    JACOBSSON, L
    JANSSON, S
    TISELL, LE
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (10) : 1638 - 1643
  • [29] Dosimetry during therapy in neuroblastoma paediatric patients treated with 131I-mIBG -: Methodology optimization and preliminary results
    Chiesa, C
    Albertini, F
    Castellani, MR
    Pavesi, R
    Luksch, R
    Bombardieri, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S474 - S474
  • [30] RADIATION BURDEN USING I-131 META-BENZYLGUANIDINE (MIBG) FOR DIAGNOSIS AND THERAPY
    KIMMIG, B
    BUBECK, B
    EISENHUT, M
    LANGE, D
    NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1983, 14 (06): : 353 - 355
12345